Radiation-Induced Cancers From Modern Radiotherapy Techniques: Intensity-Modulated Radiotherapy Versus Proton Therapy
- Proton Therapy Center, National Cancer Center, Goyang (Korea, Republic of)
Purpose: To assess and compare secondary cancer risk resulting from intensity-modulated radiotherapy (IMRT) and proton therapy in patients with prostate and head-and-neck cancer. Methods and Materials: Intensity-modulated radiotherapy and proton therapy in the scattering mode were planned for 5 prostate caner patients and 5 head-and-neck cancer patients. The secondary doses during irradiation were measured using ion chamber and CR-39 detectors for IMRT and proton therapy, respectively. Organ-specific radiation-induced cancer risk was estimated by applying organ equivalent dose to dose distributions. Results: The average secondary doses of proton therapy for prostate cancer patients, measured 20-60cm from the isocenter, ranged from 0.4 mSv/Gy to 0.1 mSv/Gy. The average secondary doses of IMRT for prostate patients, however, ranged between 3 mSv/Gy and 1 mSv/Gy, approximately one order of magnitude higher than for proton therapy. Although the average secondary doses of IMRT were higher than those of proton therapy for head-and-neck cancers, these differences were not significant. Organ equivalent dose calculations showed that, for prostate cancer patients, the risk of secondary cancers in out-of-field organs, such as the stomach, lungs, and thyroid, was at least 5 times higher for IMRT than for proton therapy, whereas the difference was lower for head-and-neck cancer patients. Conclusions: Comparisons of organ-specific organ equivalent dose showed that the estimated secondary cancer risk using scattering mode in proton therapy is either significantly lower than the cases in IMRT treatment or, at least, does not exceed the risk induced by conventional IMRT treatment.
- OSTI ID:
- 21436121
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics, Vol. 77, Issue 5; Other Information: DOI: 10.1016/j.ijrobp.2009.07.011; PII: S0360-3016(09)01028-1; Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT
Dosimetric Study of Pelvic Proton Radiotherapy for High-Risk Prostate Cancer
Related Subjects
HEAD
LUNGS
NECK
NEOPLASMS
PROSTATE
PROTONS
RADIATION DOSES
RADIATION HAZARDS
RADIOTHERAPY
STOMACH
THYROID
BARYONS
BODY
DIGESTIVE SYSTEM
DISEASES
DOSES
ELEMENTARY PARTICLES
ENDOCRINE GLANDS
FERMIONS
GASTROINTESTINAL TRACT
GLANDS
HADRONS
HAZARDS
HEALTH HAZARDS
MALE GENITALS
MEDICINE
NUCLEAR MEDICINE
NUCLEONS
ORGANS
RADIOLOGY
RESPIRATORY SYSTEM
THERAPY